Sirona Dental Systems GmbH
$108.6K 114 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Nucletron Operations B.V.
Nucletron Operations B.V. reported $108,391.29 across General Payments, Research, and Ownership to 17 physicians and teaching hospitals across 17 transactions.
- $108.4K Below-median payer
- All-tracks total
- 17 Below-median volume
- Transactions
- 17 Below-median reach
- Recipients
- +$16.7K
- General Payments vs PY2023
Nucletron Operations B.V. reported $108,391.29 across all CMS Open Payments tracks (General + Research + Ownership) to 17 physicians and teaching hospitals in Program Year 2024 - ranking #1163 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $108,391.29, averaging $6.4K per recipient.
Nucletron Operations B.V.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
17/100
Total payments
F
11/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
37/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer nucletron-operations-b-v Nucletron Operations B.V.
$108.4K · #1163/1,925 · 0.0% industry · PY2024
- TOT $108.4K
- RANK #1163
- SHARE 0.0%
- TXN 17
- RCP 17
- CAT 3
- GEN $108.4K
- ΔGEN +$16.7K
- TOP1 61.4%
- PY 2024
Volume peers
Nearest volume peer: Sirona Dental Systems GmbH ($108.6K)
Nucletron Operations B.V. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Nucletron Operations B.V.'s CMS-reported General Payments increased by $16.7K (+18.2%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: NUCLETRON OPERATIONS B.V.PY2023: NUCLETRON OPERATIONS B.V.PY2024: Nucletron Operations B.V.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $91,692.50
- PY2024
- $108,391.29
What the Data Shows for Nucletron Operations B.V.
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Nucletron Operations B.V. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
8 transactions worth $66.5K make "Royalty or License" the top general-payment category in the 3-category breakdown below, 61.4% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Nucletron Operations B.V. made 3 types of general payments. "Royalty or License" is the largest category at $66.5K, 61.4% of General Payments.
How Nucletron Operations B.V. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Royalty or License | $66.5K | 8 | 61.4% |
| Compensation for Services Other Than Consulting | $41.8K | 7 | 38.5% |
| Food and Beverage | $98.75 | 2 | 0.1% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $108,292.54 (99.9%) of $108,391.29 in this company's General Payments records across 6 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Nucletron Operations B.V.
The five named recipients with the highest reported General Payments from this company
- 1
Ronald Reagan Ucla
$66,539.19 across 8 reported transactions
- 2
Ut Md Anderson Cancer Center
$15,582.26 across 4 reported transactions
- 3
Brigham And Womens Hospital
$13,850.00 across 1 reported transactions
- 4
Uh Cleveland Medical Center
$10,100.00 across 1 reported transactions
- 5
Karim Touijer
$2,221.09 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Nucletron Operations B.V. ranks #1163 of 1,925 by total payments (bottom 40% by spend) but is notably more concentrated than that alone would suggest -- #434 of 1,838 by HHI (top 24% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Oasis Medical, Inc. : $94.3K total payments, HHI 4288
- Consortium of Independent Immunology Clinics, LLC : $225.3K total payments, HHI 4285
- Evolved By Nature, Inc. : $239.3K total payments, HHI 4275
- Cochlear Ltd : $10.1K total payments, HHI 4273
- Change Healthcare Technologies, LLC : $89.9K total payments, HHI 4271
- Owens & Minor Distribution, Inc. : $316.70 total payments, HHI 4269
- Nucletron Operations B.V. (this company) : $108.4K total payments, HHI 4229
- Signature Orthopaedics USA Corp : $42.1K total payments, HHI 4228
- Clariance SAS : $73.8K total payments, HHI 4220
- Nova Eye, Inc. : $404.7K total payments, HHI 4216
- Lightscalpel Inc : $22.2K total payments, HHI 4194
- Dentium Co., Ltd : $56.4K total payments, HHI 4184
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Nucletron Operations B.V.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Nucletron Operations B.V..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Nucletron Operations B.V..
Showing 6 of 1,924 companies with CMS-reported payment data.
Visionix USA, Inc
$108.9K 85 recipients
Compare payment profiles
Neoss, Inc.
$107.6K 375 recipients
Compare payment profiles
Swing Therapeutics, Inc.
$107.4K 26 recipients
Compare payment profiles
Elevate Oral Care
$109.5K 846 recipients
Compare payment profiles
60 Degrees Pharmaceuticals
$109.6K 10 recipients
Compare payment profiles
Put this to use
Nucletron Operations B.V. ranks #1163 of 1,925 by all-tracks total payments, led by "Royalty or License".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Royalty or License" spend across every manufacturer, not just Nucletron Operations B.V.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.